Fabrazyme (Agalsidase Beta) - Drug Interactions, Contraindications, Overdosage

Rx drug information, pharmaceutical research, clinical trials, news, and more

No drug interaction studies were performed.

No in vitro metabolism studies were performed.

OVERDOSAGE

There have been no reports of overdose with Fabrazyme®. In clinical trials, patients received doses up to 3.0 mg/kg body weight.

No known contraindications.

Page last updated: 2006-08-08

-- advertisement --

We comply with
HONcode standard.
Verify here.